Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series

Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality usin...

Full description

Saved in:
Bibliographic Details
Published inThe Lancet global health Vol. 5; no. 10; pp. e984 - e991
Main Authors Scheltema, Nienke M, Gentile, Angela, Lucion, Florencia, Nokes, D James, Munywoki, Patrick K, Madhi, Shabir A, Groome, Michelle J, Cohen, Cheryl, Moyes, Jocelyn, Thorburn, Kentigern, Thamthitiwat, Somsak, Oshitani, Hitoshi, Lupisan, Socorro P, Gordon, Aubree, Sánchez, José F, O'Brien, Katherine L, Gessner, Bradford D, Sutanto, Agustinus, Mejias, Asuncion, Ramilo, Octavio, Khuri-Bulos, Najwa, Halasa, Natasha, de-Paris, Fernanda, Pires, Márcia Rosane, Spaeder, Michael C, Paes, Bosco A, Simões, Eric A F, Leung, Ting F, da Costa Oliveira, Maria Tereza, de Freitas Lázaro Emediato, Carla Cecília, Bassat, Quique, Butt, Warwick, Chi, Hsin, Aamir, Uzma Bashir, Ali, Asad, Lucero, Marilla G, Fasce, Rodrigo A, Lopez, Olga, Rath, Barbara A, Polack, Fernando P, Papenburg, Jesse, Roglić, Srđan, Ito, Hisato, Goka, Edward A, Grobbee, Diederick E, Nair, Harish, Bont, Louis J
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.10.2017
The Lancet Global Health
Elsevier
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 months (2·0–10·0) in upper middle-income countries, and 7·0 months (3·6–16·8) in high-income countries. This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries. Bill & Melinda Gates Foundation.
AbstractList Background: Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. Methods: In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. Findings: We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 years (2·0–10·0) in upper middle-income countries, and 7·0 years (3·6–16·8) in high-income countries. Interpretation: This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries. Funding: Bill & Melinda Gates Foundation.
Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. Methods In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. Findings We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 months (2·0–10·0) in upper middle-income countries, and 7·0 months (3·6–16·8) in high-income countries. Interpretation This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries.
Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms “RSV”, “respiratory syncytial virus”, or “respiratory syncytial viral” combined with “mortality”, “fatality”, “death”, “died”, “deaths”, or “CFR” for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3–11·0) in low-income or lower middle-income countries, 4·0 months (2·0–10·0) in upper middle-income countries, and 7·0 months (3·6–16·8) in high-income countries. This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries. Bill & Melinda Gates Foundation.
Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data.BACKGROUNDRespiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data.In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms "RSV", "respiratory syncytial virus", or "respiratory syncytial viral" combined with "mortality", "fatality", "death", "died", "deaths", or "CFR" for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables.METHODSIn this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms "RSV", "respiratory syncytial virus", or "respiratory syncytial viral" combined with "mortality", "fatality", "death", "died", "deaths", or "CFR" for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables.We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3-11·0) in low-income or lower middle-income countries, 4·0 years (2·0-10·0) in upper middle-income countries, and 7·0 years (3·6-16·8) in high-income countries.FINDINGSWe studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3-11·0) in low-income or lower middle-income countries, 4·0 years (2·0-10·0) in upper middle-income countries, and 7·0 years (3·6-16·8) in high-income countries.This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries.INTERPRETATIONThis study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries.Bill & Melinda Gates Foundation.FUNDINGBill & Melinda Gates Foundation.
Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are scarce. We aimed to identify clinical and socioeconomic characteristics of children aged younger than 5 years with RSV-related mortality using individual patient data. In this retrospective case series, we developed an online questionnaire to obtain individual patient data for clinical and socioeconomic characteristics of children aged younger than 5 years who died with community-acquired RSV infection between Jan 1, 1995, and Oct 31, 2015, through leading research groups for child pneumonia identified through a comprehensive literature search and existing research networks. For the literature search, we searched PubMed for articles published up to Feb 3, 2015, using the key terms "RSV", "respiratory syncytial virus", or "respiratory syncytial viral" combined with "mortality", "fatality", "death", "died", "deaths", or "CFR" for articles published in English. We invited researchers and clinicians identified to participate between Nov 1, 2014, and Oct 31, 2015. We calculated descriptive statistics for all variables. We studied 358 children with RSV-related in-hospital death from 23 countries across the world, with data contributed from 31 research groups. 117 (33%) children were from low-income or lower middle-income countries, 77 (22%) were from upper middle-income countries, and 164 (46%) were from high-income countries. 190 (53%) were male. Data for comorbidities were missing for some children in low-income and middle-income countries. Available data showed that comorbidities were present in at least 33 (28%) children from low-income or lower middle-income countries, 36 (47%) from upper middle-income countries, and 114 (70%) from high-income countries. Median age for RSV-related deaths was 5·0 months (IQR 2·3-11·0) in low-income or lower middle-income countries, 4·0 years (2·0-10·0) in upper middle-income countries, and 7·0 years (3·6-16·8) in high-income countries. This study is the first large case series of children who died with community-acquired RSV infection. A substantial proportion of children with RSV-related death had comorbidities. Our results show that perinatal immunisation strategies for children aged younger than 6 months could have a substantial impact on RSV-related child mortality in low-income and middle-income countries. Bill & Melinda Gates Foundation.
Author Thorburn, Kentigern
Papenburg, Jesse
Chi, Hsin
Lucion, Florencia
Madhi, Shabir A
Khuri-Bulos, Najwa
Sánchez, José F
O'Brien, Katherine L
Paes, Bosco A
Goka, Edward A
Gessner, Bradford D
Lucero, Marilla G
Nair, Harish
de-Paris, Fernanda
Moyes, Jocelyn
Munywoki, Patrick K
Halasa, Natasha
Lopez, Olga
Bont, Louis J
Gordon, Aubree
Sutanto, Agustinus
Grobbee, Diederick E
Oshitani, Hitoshi
Groome, Michelle J
Ito, Hisato
Lupisan, Socorro P
Ali, Asad
Gentile, Angela
Cohen, Cheryl
Simões, Eric A F
Bassat, Quique
da Costa Oliveira, Maria Tereza
de Freitas Lázaro Emediato, Carla Cecília
Thamthitiwat, Somsak
Aamir, Uzma Bashir
Polack, Fernando P
Pires, Márcia Rosane
Butt, Warwick
Roglić, Srđan
Mejias, Asuncion
Scheltema, Nienke M
Rath, Barbara A
Ramilo, Octavio
Fasce, Rodrigo A
Nokes, D James
Leung, Ting F
Spaeder, Michael C
AuthorAffiliation l Department of Virology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Miyagi, Japan
p International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
ar University of Nottingham School of Medicine, Nottingham, UK
am Department of Virology, National Institute of Health, Islamabad, Pakistan
aa Department of Pediatrics and Center for Global Health, University of Colorado, Aurora, CO, USA
ay Julius Clinical Science, Zeist, Netherlands
ae ICREA, Catalan Institution for Research and Advanced Studies, Barcelona, Spain
d Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographic Medicine Research—Coast, Kilifi, Kenya
h School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
c Department of Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina
ai Department of Intensive Care, Royal Children's Hospital, Melbourne, VIC, Australia
z Neonatal Division, Department of
AuthorAffiliation_xml – name: j Department of Paediatric Intensive Care, Alder Hey Children's Hospital, Liverpool, UK
– name: ag Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique
– name: q Agence de Medecine Preventive, Paris, France
– name: av Department of Pediatrics, Nantan General Hospital, Ueno, Yagichoyagi, Nantan-shi, Kyoto, Japan
– name: r West Nusa Tenggara Provincial Government, Lombok, Indonesia
– name: aq Vienna Vaccine Safety Initiative, Berlin, Germany
– name: ar University of Nottingham School of Medicine, Nottingham, UK
– name: ad ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
– name: i Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa
– name: ay Julius Clinical Science, Zeist, Netherlands
– name: t Center for Vaccines and Immunity at Nationwide Children's Hospital, Ohio State University, Columbus, OH, USA
– name: az Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
– name: v Vanderbilt University Medical Center, Nashville, TN, USA
– name: ao Public Health Institute, Ñuñoa, Santiago, Chile
– name: at Department of Microbiology, Division of Pediatric Infectious Diseases, McGill University Health Centre, Montreal, QC, Canada
– name: h School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
– name: af Department of Pediatrics, Hospital Sant Joan de Déu, Barcelona, Spain
– name: am Department of Virology, National Institute of Health, Islamabad, Pakistan
– name: e School of Life Sciences, University of Warwick, Coventry, UK
– name: u Department of Pediatrics, University of Jordan, Aljubeiha, Amman, Jordan
– name: au Department of Paediatric Infectious Diseases, University Hospital for Infectious Diseases, Zagreb, Croatia
– name: k Division of Global Health Protection, Thailand Ministry of Public Health—US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
– name: ae ICREA, Catalan Institution for Research and Advanced Studies, Barcelona, Spain
– name: f Department of Nursing Sciences, Pwani University, Kilifi, Kenya
– name: ap Hospital Dr. Ernesto Torres Galdames, Iquique, Chile
– name: s Department of Pediatrics, Division of Infectious Diseases, Ohio State University, Columbus, OH, USA
– name: d Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographic Medicine Research—Coast, Kilifi, Kenya
– name: l Department of Virology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Miyagi, Japan
– name: p International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
– name: aa Department of Pediatrics and Center for Global Health, University of Colorado, Aurora, CO, USA
– name: w Molecular Biology Laboratory, Hospital de Clínicas de Porto Alegre, Bairro Santa Cecília, Porto Alegre, Brazil
– name: z Neonatal Division, Department of Pediatrics, McMaster University, Hamilton, ON, Canada
– name: ai Department of Intensive Care, Royal Children's Hospital, Melbourne, VIC, Australia
– name: b ReSViNET Respiratory Syncytial Virus Network, Utrecht, Netherlands
– name: aj Department of Paediatrics, University of Melbourne, Melbourne, VIC, Australia
– name: c Department of Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina
– name: ax Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands
– name: an Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan
– name: a Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands
– name: ak Murdoch Children's Research Institute, Parkville, VIC, Australia
– name: g Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa
– name: ah Faculty of Medicine, Universidad Europea de Madrid, Madrid, Spain
– name: y Division of Pediatric Critical Care, University of Virginia School of Medicine, Charlottesville, VA, USA
– name: x Infection Control Commission, Hospital de Clínicas de Porto Alegre, Bairro Santa Cecília, Porto Alegre, Brazil
– name: al Department of Pediatric Infectious Disease, MacKay Children's Hospital, Taipei, Taiwan
– name: ab Department of Paediatrics, Faculty of Medicine and Chinese University of Hong Kong-University Medical Center Utrecht Joint Research Laboratory of Respiratory Virus and Immunobiology, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region, China
– name: as Fundacion Infant, Buenos Aires, Argentina
– name: n Department of Epidemiology, School of Public Health, University of Michigan, MI, USA
– name: m Research Institute for Tropical Medicine, Alabang Muntinlupa City, Metro Manila Philippines
– name: aw School of Health and Related Research, University of Sheffield, Sheffield, UK
– name: o Department of Medicine, Hospital Infantil Manuel de Jesus Rivera, Managua, Nicaragua
– name: ac Health Secretariat of the City of Belo Horizonte, Belo Horizonte, Brazil
Author_xml – sequence: 1
  givenname: Nienke M
  surname: Scheltema
  fullname: Scheltema, Nienke M
  organization: Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands
– sequence: 2
  givenname: Angela
  surname: Gentile
  fullname: Gentile, Angela
  organization: Department of Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina
– sequence: 3
  givenname: Florencia
  surname: Lucion
  fullname: Lucion, Florencia
  organization: Department of Epidemiology, Ricardo Gutiérrez Children's Hospital, Buenos Aires, Argentina
– sequence: 4
  givenname: D James
  surname: Nokes
  fullname: Nokes, D James
  organization: Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographic Medicine Research—Coast, Kilifi, Kenya
– sequence: 5
  givenname: Patrick K
  surname: Munywoki
  fullname: Munywoki, Patrick K
  organization: Kenya Medical Research Institute, Wellcome Trust Research Programme, Centre for Geographic Medicine Research—Coast, Kilifi, Kenya
– sequence: 6
  givenname: Shabir A
  surname: Madhi
  fullname: Madhi, Shabir A
  organization: Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 7
  givenname: Michelle J
  surname: Groome
  fullname: Groome, Michelle J
  organization: Medical Research Council: Respiratory and Meningeal Pathogens Research Unit and Department of Science and Technology/National Research Foundation: Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 8
  givenname: Cheryl
  surname: Cohen
  fullname: Cohen, Cheryl
  organization: School of Public Health, University of the Witwatersrand, Johannesburg, South Africa
– sequence: 9
  givenname: Jocelyn
  surname: Moyes
  fullname: Moyes, Jocelyn
  organization: Centre for Respiratory Disease and Meningitis, National Institute for Communicable Diseases, Johannesburg, South Africa
– sequence: 10
  givenname: Kentigern
  surname: Thorburn
  fullname: Thorburn, Kentigern
  organization: Department of Paediatric Intensive Care, Alder Hey Children's Hospital, Liverpool, UK
– sequence: 11
  givenname: Somsak
  surname: Thamthitiwat
  fullname: Thamthitiwat, Somsak
  organization: Division of Global Health Protection, Thailand Ministry of Public Health—US Centers for Disease Control and Prevention Collaboration, Nonthaburi, Thailand
– sequence: 12
  givenname: Hitoshi
  surname: Oshitani
  fullname: Oshitani, Hitoshi
  organization: Department of Virology, Tohoku University Graduate School of Medicine, Aoba-ku, Sendai, Miyagi, Japan
– sequence: 13
  givenname: Socorro P
  surname: Lupisan
  fullname: Lupisan, Socorro P
  organization: Research Institute for Tropical Medicine, Alabang Muntinlupa City, Metro Manila Philippines
– sequence: 14
  givenname: Aubree
  surname: Gordon
  fullname: Gordon, Aubree
  organization: Department of Epidemiology, School of Public Health, University of Michigan, MI, USA
– sequence: 15
  givenname: José F
  surname: Sánchez
  fullname: Sánchez, José F
  organization: Department of Medicine, Hospital Infantil Manuel de Jesus Rivera, Managua, Nicaragua
– sequence: 16
  givenname: Katherine L
  surname: O'Brien
  fullname: O'Brien, Katherine L
  organization: International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA
– sequence: 17
  givenname: Bradford D
  surname: Gessner
  fullname: Gessner, Bradford D
  organization: Agence de Medecine Preventive, Paris, France
– sequence: 18
  givenname: Agustinus
  surname: Sutanto
  fullname: Sutanto, Agustinus
  organization: West Nusa Tenggara Provincial Government, Lombok, Indonesia
– sequence: 19
  givenname: Asuncion
  surname: Mejias
  fullname: Mejias, Asuncion
  organization: Department of Pediatrics, Division of Infectious Diseases, Ohio State University, Columbus, OH, USA
– sequence: 20
  givenname: Octavio
  surname: Ramilo
  fullname: Ramilo, Octavio
  organization: Department of Pediatrics, Division of Infectious Diseases, Ohio State University, Columbus, OH, USA
– sequence: 21
  givenname: Najwa
  surname: Khuri-Bulos
  fullname: Khuri-Bulos, Najwa
  organization: Department of Pediatrics, University of Jordan, Aljubeiha, Amman, Jordan
– sequence: 22
  givenname: Natasha
  surname: Halasa
  fullname: Halasa, Natasha
  organization: Vanderbilt University Medical Center, Nashville, TN, USA
– sequence: 23
  givenname: Fernanda
  surname: de-Paris
  fullname: de-Paris, Fernanda
  organization: Molecular Biology Laboratory, Hospital de Clínicas de Porto Alegre, Bairro Santa Cecília, Porto Alegre, Brazil
– sequence: 24
  givenname: Márcia Rosane
  surname: Pires
  fullname: Pires, Márcia Rosane
  organization: Infection Control Commission, Hospital de Clínicas de Porto Alegre, Bairro Santa Cecília, Porto Alegre, Brazil
– sequence: 25
  givenname: Michael C
  surname: Spaeder
  fullname: Spaeder, Michael C
  organization: Division of Pediatric Critical Care, University of Virginia School of Medicine, Charlottesville, VA, USA
– sequence: 26
  givenname: Bosco A
  surname: Paes
  fullname: Paes, Bosco A
  organization: Neonatal Division, Department of Pediatrics, McMaster University, Hamilton, ON, Canada
– sequence: 27
  givenname: Eric A F
  surname: Simões
  fullname: Simões, Eric A F
  organization: Department of Pediatrics and Center for Global Health, University of Colorado, Aurora, CO, USA
– sequence: 28
  givenname: Ting F
  surname: Leung
  fullname: Leung, Ting F
  organization: Department of Paediatrics, Faculty of Medicine and Chinese University of Hong Kong-University Medical Center Utrecht Joint Research Laboratory of Respiratory Virus and Immunobiology, Chinese University of Hong Kong, Shatin, New Territories, Hong Kong Special Administrative Region, China
– sequence: 29
  givenname: Maria Tereza
  surname: da Costa Oliveira
  fullname: da Costa Oliveira, Maria Tereza
  organization: Health Secretariat of the City of Belo Horizonte, Belo Horizonte, Brazil
– sequence: 30
  givenname: Carla Cecília
  surname: de Freitas Lázaro Emediato
  fullname: de Freitas Lázaro Emediato, Carla Cecília
  organization: Health Secretariat of the City of Belo Horizonte, Belo Horizonte, Brazil
– sequence: 31
  givenname: Quique
  surname: Bassat
  fullname: Bassat, Quique
  organization: ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic-Universitat de Barcelona, Barcelona, Spain
– sequence: 32
  givenname: Warwick
  surname: Butt
  fullname: Butt, Warwick
  organization: Department of Intensive Care, Royal Children's Hospital, Melbourne, VIC, Australia
– sequence: 33
  givenname: Hsin
  surname: Chi
  fullname: Chi, Hsin
  organization: Department of Pediatric Infectious Disease, MacKay Children's Hospital, Taipei, Taiwan
– sequence: 34
  givenname: Uzma Bashir
  surname: Aamir
  fullname: Aamir, Uzma Bashir
  organization: Department of Virology, National Institute of Health, Islamabad, Pakistan
– sequence: 35
  givenname: Asad
  surname: Ali
  fullname: Ali, Asad
  organization: Department of Paediatrics and Child Health, Aga Khan University, Karachi, Pakistan
– sequence: 36
  givenname: Marilla G
  surname: Lucero
  fullname: Lucero, Marilla G
  organization: Research Institute for Tropical Medicine, Alabang Muntinlupa City, Metro Manila Philippines
– sequence: 37
  givenname: Rodrigo A
  surname: Fasce
  fullname: Fasce, Rodrigo A
  organization: Public Health Institute, Ñuñoa, Santiago, Chile
– sequence: 38
  givenname: Olga
  surname: Lopez
  fullname: Lopez, Olga
  organization: Hospital Dr. Ernesto Torres Galdames, Iquique, Chile
– sequence: 39
  givenname: Barbara A
  surname: Rath
  fullname: Rath, Barbara A
  organization: Vienna Vaccine Safety Initiative, Berlin, Germany
– sequence: 40
  givenname: Fernando P
  surname: Polack
  fullname: Polack, Fernando P
  organization: Fundacion Infant, Buenos Aires, Argentina
– sequence: 41
  givenname: Jesse
  surname: Papenburg
  fullname: Papenburg, Jesse
  organization: Department of Microbiology, Division of Pediatric Infectious Diseases, McGill University Health Centre, Montreal, QC, Canada
– sequence: 42
  givenname: Srđan
  surname: Roglić
  fullname: Roglić, Srđan
  organization: Department of Paediatric Infectious Diseases, University Hospital for Infectious Diseases, Zagreb, Croatia
– sequence: 43
  givenname: Hisato
  surname: Ito
  fullname: Ito, Hisato
  organization: Department of Pediatrics, Nantan General Hospital, Ueno, Yagichoyagi, Nantan-shi, Kyoto, Japan
– sequence: 44
  givenname: Edward A
  surname: Goka
  fullname: Goka, Edward A
  organization: School of Health and Related Research, University of Sheffield, Sheffield, UK
– sequence: 45
  givenname: Diederick E
  surname: Grobbee
  fullname: Grobbee, Diederick E
  organization: Julius Global Health, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, Netherlands
– sequence: 46
  givenname: Harish
  surname: Nair
  fullname: Nair, Harish
  organization: Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK
– sequence: 47
  givenname: Louis J
  surname: Bont
  fullname: Bont, Louis J
  email: l.bont@umcutrecht.nl
  organization: Department of Paediatric Infectious Diseases and Immunology, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, Netherlands
BackLink https://www.ncbi.nlm.nih.gov/pubmed/28911764$$D View this record in MEDLINE/PubMed
BookMark eNqNkt9v0zAQxyM0xMbYnwDK4_YQ8M8kBgFCA8qkSpMYIN4sx7l0Hm7c2U6l_Pc4bam2vQxLlu3zfT_n893z7KB3PWTZS4xeY4TLN1eEYFZgJH6f4uqMIspYQZ9kR3vzwZ39YXYSwg1KQwhKqupZdkhqgXFVsqPsdmZdo2zuIayMV9H5MQ9jr8doknVt_BAKFYLTRkVo86XzUVkTx9z0-eiGfpHra2NbD31--v3qVz67nH8-e5urBIzehRXoaNaQaxUgD-ANhBfZ007ZACe79Tj7-fXLj_NvxfxydnH-aV7okohY8LbElHeEN4xB2_GWUFITRIVihHEloKkRKzkVVQk16kgDyRfXlCa7ajWix9nFlts6dSNX3iyVH6VTRm4Mzi-k8tFoC7LEXUc7zlEpNNO1aKCkpGGkqSrOgYrE-rBlrYZmCa2GPnpl70Hv3_TmWi7cWnKe_hyxBMBbgA6Dlh40eK3iRrg_TJOgikgiaFlNQU93Qb27HSBEuTRBg7WqBzcEiQVDiAkqplxf3X3f_mH_6pwc-C5-Kkrw0O1dMJJTS8lNS8mpXySu5KalJE26dw902kQVjZvSNPZR9cetGlKd1wa8DNpAr6E1KeuYCmEeJbx_QNDW9EYr-wfG_9D_BYXL-Qo
CitedBy_id crossref_primary_10_1055_s_0042_1760446
crossref_primary_10_1002_ppul_25435
crossref_primary_10_1093_cid_ciab488
crossref_primary_10_1002_14651858_CD010473_pub4
crossref_primary_10_1152_ajpheart_00018_2021
crossref_primary_10_1186_s12982_021_00104_5
crossref_primary_10_1155_2020_8919534
crossref_primary_10_1093_cid_ciab486
crossref_primary_10_1097_INF_0000000000002271
crossref_primary_10_1016_j_meegid_2019_03_026
crossref_primary_10_1186_s12887_021_02675_3
crossref_primary_10_1016_j_clim_2019_108324
crossref_primary_10_1002_14651858_CD010473_pub3
crossref_primary_10_1097_INF_0000000000003121
crossref_primary_10_1016_j_dche_2024_100214
crossref_primary_10_1016_S2214_109X_17_30348_0
crossref_primary_10_1177_20499361221128091
crossref_primary_10_1093_infdis_jiac078
crossref_primary_10_1128_jvi_01341_22
crossref_primary_10_1891_0730_0832_11_T_693
crossref_primary_10_1016_S2542_5196_20_30297_7
crossref_primary_10_1542_peds_2020_1727
crossref_primary_10_1002_jmv_25917
crossref_primary_10_1097_INF_0000000000003416
crossref_primary_10_1016_j_arcmed_2019_10_005
crossref_primary_10_1021_acsinfecdis_9b00524
crossref_primary_10_1007_s40475_018_0156_4
crossref_primary_10_5812_ijp_89082
crossref_primary_10_1007_s40272_023_00598_3
crossref_primary_10_1186_s12887_019_1649_6
crossref_primary_10_1016_j_diagmicrobio_2019_04_006
crossref_primary_10_1016_j_vaccine_2021_03_096
crossref_primary_10_3390_v12050521
crossref_primary_10_3389_fgene_2021_633125
crossref_primary_10_1080_17476348_2020_1807945
crossref_primary_10_1007_s10096_018_3409_1
crossref_primary_10_1093_infdis_jiac481
crossref_primary_10_1097_INF_0000000000003538
crossref_primary_10_1186_s12879_020_4882_6
crossref_primary_10_1007_s10096_019_03588_x
crossref_primary_10_1128_jvi_02029_24
crossref_primary_10_1016_j_cyto_2019_154965
crossref_primary_10_1093_ve_veaa050
crossref_primary_10_1016_j_xcrm_2023_101081
crossref_primary_10_1002_ppul_24804
crossref_primary_10_1007_s13312_024_3310_1
crossref_primary_10_1002_rmv_2284
crossref_primary_10_1016_j_aller_2019_10_007
crossref_primary_10_1016_j_biopha_2021_111843
crossref_primary_10_1016_j_sste_2021_100434
crossref_primary_10_3389_fcimb_2019_00075
crossref_primary_10_3389_fped_2025_1482029
crossref_primary_10_1186_s12879_022_07261_1
crossref_primary_10_3390_v15040993
crossref_primary_10_1016_S1473_3099_18_30292_5
crossref_primary_10_1099_jgv_0_001287
crossref_primary_10_1097_INF_0000000000003747
crossref_primary_10_1111_irv_12893
crossref_primary_10_1111_irv_12771
crossref_primary_10_3390_ijerph17020564
crossref_primary_10_1016_j_vaccine_2018_06_021
crossref_primary_10_1371_journal_pmed_1004250
crossref_primary_10_1002_ppul_23963
crossref_primary_10_1097_INF_0000000000002666
crossref_primary_10_1093_cid_ciy413
crossref_primary_10_1097_INF_0000000000004682
crossref_primary_10_1111_irv_12639
crossref_primary_10_1093_infdis_jiaa046
crossref_primary_10_2196_13377
crossref_primary_10_1080_14787210_2019_1581062
crossref_primary_10_1055_s_0041_1731409
crossref_primary_10_1093_cid_ciz585
crossref_primary_10_1186_s12879_024_10024_9
crossref_primary_10_1002_14651858_CD004873_pub6
crossref_primary_10_3389_fmicb_2023_1173842
crossref_primary_10_1097_01_JAA_0000694944_22382_39
crossref_primary_10_1016_j_ajic_2021_10_027
crossref_primary_10_1016_j_virs_2025_01_003
crossref_primary_10_1093_infdis_jiz161
crossref_primary_10_3390_pathogens13090802
crossref_primary_10_1002_ppul_25114
crossref_primary_10_1016_j_lanepe_2024_100965
crossref_primary_10_1016_j_eclinm_2021_100945
crossref_primary_10_1164_rccm_201712_2567OC
crossref_primary_10_1371_journal_ppat_1011597
crossref_primary_10_1542_hpeds_2022_006542
crossref_primary_10_7554_eLife_46202
crossref_primary_10_1016_j_jped_2022_10_004
crossref_primary_10_1097_INF_0000000000004375
crossref_primary_10_1186_s12978_018_0528_1
crossref_primary_10_3390_ijms241411445
crossref_primary_10_1128_JVI_01407_20
crossref_primary_10_1590_1984_0462_2024_42_2022215
crossref_primary_10_1007_s00431_018_3168_0
crossref_primary_10_1128_JVI_01201_20
crossref_primary_10_1016_j_antiviral_2023_105791
crossref_primary_10_1016_j_cpem_2018_02_011
crossref_primary_10_1128_JVI_01322_17
crossref_primary_10_28982_josam_632224
crossref_primary_10_3389_fped_2022_979777
crossref_primary_10_1136_thoraxjnl_2020_216291
crossref_primary_10_1080_14787210_2018_1543589
crossref_primary_10_1016_S2213_2600_20_30109_0
crossref_primary_10_3390_antiox10121874
crossref_primary_10_1016_j_aller_2019_04_004
crossref_primary_10_1093_infdis_jiaa309
crossref_primary_10_1002_jcph_1140
crossref_primary_10_1093_infdis_jiaa424
crossref_primary_10_1007_s40121_020_00390_7
crossref_primary_10_1016_j_vaccine_2018_10_041
crossref_primary_10_1016_S1473_3099_22_00291_2
crossref_primary_10_3390_v15081760
crossref_primary_10_1371_journal_ppat_1009428
crossref_primary_10_3390_vaccines7010003
crossref_primary_10_1093_ofid_ofae679
crossref_primary_10_1007_s40203_023_00178_w
crossref_primary_10_1093_infdis_jiae467
crossref_primary_10_2217_fvl_2020_0174
crossref_primary_10_1056_NEJMoa2106062
crossref_primary_10_3390_metabo12020178
crossref_primary_10_3389_fimmu_2024_1438630
crossref_primary_10_3390_v13122478
crossref_primary_10_1016_j_vaccine_2020_04_075
crossref_primary_10_1038_s41467_021_23859_6
crossref_primary_10_53126_MEB41632
crossref_primary_10_1021_acsomega_8b01600
crossref_primary_10_1080_14787210_2021_1828866
crossref_primary_10_1136_thoraxjnl_2018_212212
crossref_primary_10_1093_cid_ciz017
crossref_primary_10_3390_vaccines9090961
crossref_primary_10_1093_infdis_jiaa751
crossref_primary_10_1097_INF_0000000000002297
crossref_primary_10_1177_2515135520981516
crossref_primary_10_3390_children9060848
crossref_primary_10_1016_j_prrv_2019_04_003
crossref_primary_10_1016_j_ijid_2022_10_039
crossref_primary_10_1080_21645515_2020_1843336
crossref_primary_10_1126_scitranslmed_aaw0268
crossref_primary_10_1007_s00431_018_03308_1
crossref_primary_10_3389_fped_2022_997349
crossref_primary_10_3390_v13061023
crossref_primary_10_1080_14737159_2018_1487293
crossref_primary_10_1097_INF_0000000000003398
crossref_primary_10_1542_hpeds_2020_005702
crossref_primary_10_3390_children10061081
crossref_primary_10_1093_cid_ciab497
crossref_primary_10_1016_j_meegid_2024_105694
crossref_primary_10_1089_vim_2018_0121
crossref_primary_10_1126_scitranslmed_ade6422
crossref_primary_10_2217_fca_2017_0096
crossref_primary_10_1183_23120541_00135_2020
crossref_primary_10_3390_biomimetics7010003
crossref_primary_10_3998_lacs_7017
crossref_primary_10_1038_s41598_021_88524_w
crossref_primary_10_1093_jpids_piad042
crossref_primary_10_1080_14760584_2023_2189459
crossref_primary_10_3389_fcimb_2022_858629
crossref_primary_10_7189_jogh_13_04001
crossref_primary_10_3390_microorganisms13010140
crossref_primary_10_1093_cid_ciab528
crossref_primary_10_3390_vaccines8020177
crossref_primary_10_1164_rccm_201810_1921OC
crossref_primary_10_4049_jimmunol_2100018
crossref_primary_10_1038_s41591_019_0392_8
crossref_primary_10_1186_s12879_021_06544_3
crossref_primary_10_1016_j_jvacx_2023_100379
Cites_doi 10.1093/infdis/jit479
10.1016/j.vaccine.2015.05.093
10.1007/s00431-010-1376-3
10.1542/peds.2014-2151
10.1016/S0140-6736(12)61728-0
10.1185/03007995.2010.505126
10.1001/jama.2010.675
10.1186/1756-0500-6-447
10.1007/s15010-008-8130-z
10.1164/rccm.201603-0658OC
10.1016/S0140-6736(12)61901-1
10.1371/journal.pone.0089978
10.1093/infdis/jit517
10.1136/jech.2004.026450
10.1136/adc.2008.139188
10.1542/peds.2013-0303
10.1097/INF.0000000000001163
10.1371/journal.pone.0018176
10.1086/317655
10.1016/j.jmii.2014.08.020
10.1016/j.vaccine.2016.02.078
10.1111/ped.12051
10.1007/s15010-013-0557-1
10.1097/INF.0000000000001262
10.1016/S0929-6646(11)60057-0
10.1016/S2213-2600(15)00255-6
10.1016/S0140-6736(17)30938-8
ContentType Journal Article
Copyright 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
cc by (c) Scheltema et. al, 2017 info:eu-repo/semantics/openAccess http://creativecommons.org/licenses/by/4.0
2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2017
Copyright_xml – notice: 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
– notice: Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
– notice: cc by (c) Scheltema et. al, 2017 info:eu-repo/semantics/openAccess <a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a>
– notice: 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license 2017
CorporateAuthor PERCH Study Group
CorporateAuthor_xml – name: PERCH Study Group
DBID 6I.
AAFTH
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
XX2
5PM
DOA
DOI 10.1016/S2214-109X(17)30344-3
DatabaseName ScienceDirect Open Access Titles
Elsevier:ScienceDirect:Open Access
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Recercat
PubMed Central (Full Participant titles)
Directory of Open Access Journals (DOAJ)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList


MEDLINE - Academic

MEDLINE
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ Directory of Open Access Journals
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Public Health
EISSN 2214-109X
EndPage e991
ExternalDocumentID oai_doaj_org_article_61ff3f55069c4c89be632b42b7755e39
PMC5599304
oai_recercat_cat_2072_293679
28911764
10_1016_S2214_109X_17_30344_3
S2214109X17303443
Genre Research Support, Non-U.S. Gov't
Journal Article
GrantInformation Bill & Melinda Gates Foundation.
GrantInformation_xml – fundername: Wellcome Trust
– fundername: NCIRD CDC HHS
  grantid: U01 IP001048
GroupedDBID .1-
.FO
0R~
1P~
457
53G
AAEDT
AAEDW
AAIKJ
AALRI
AAMRU
AAXUO
AAYWO
ABMAC
ACGFS
ACHQT
ACVFH
ADBBV
ADCNI
ADEZE
ADVLN
AENEX
AEUPX
AEVXI
AEXQZ
AFPUW
AFRHN
AFTJW
AGHFR
AIGII
AITUG
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
APXCP
BAWUL
BCNDV
DIK
EBS
EJD
FDB
GROUPED_DOAJ
HZ~
IPNFZ
IXB
KQ8
M41
M~E
O9-
OD.
OK1
OO~
RIG
ROL
SSZ
Z5R
0SF
6I.
AACTN
AAFTH
AFCTW
NCXOZ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
XX2
5PM
ID FETCH-LOGICAL-c629t-5d6135f25b44edf5d23282039a4245a9eb804653976e80f2bef251833b80adc03
IEDL.DBID IXB
ISSN 2214-109X
IngestDate Wed Aug 27 01:25:20 EDT 2025
Thu Aug 21 13:55:45 EDT 2025
Fri Aug 29 12:36:20 EDT 2025
Fri Jul 11 00:26:23 EDT 2025
Thu Apr 03 07:00:20 EDT 2025
Thu Apr 24 22:53:57 EDT 2025
Tue Jul 01 00:52:22 EDT 2025
Wed May 17 01:33:45 EDT 2023
Tue Aug 26 16:32:30 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Language English
License This is an open access article under the CC BY license.
Copyright © 2017 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license. Published by Elsevier Ltd.. All rights reserved.
This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c629t-5d6135f25b44edf5d23282039a4245a9eb804653976e80f2bef251833b80adc03
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
Contributed equally
OpenAccessLink https://www.sciencedirect.com/science/article/pii/S2214109X17303443
PMID 28911764
PQID 1940049390
PQPubID 23479
PageCount 8
ParticipantIDs doaj_primary_oai_doaj_org_article_61ff3f55069c4c89be632b42b7755e39
pubmedcentral_primary_oai_pubmedcentral_nih_gov_5599304
csuc_recercat_oai_recercat_cat_2072_293679
proquest_miscellaneous_1940049390
pubmed_primary_28911764
crossref_primary_10_1016_S2214_109X_17_30344_3
crossref_citationtrail_10_1016_S2214_109X_17_30344_3
elsevier_sciencedirect_doi_10_1016_S2214_109X_17_30344_3
elsevier_clinicalkey_doi_10_1016_S2214_109X_17_30344_3
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-10-01
PublicationDateYYYYMMDD 2017-10-01
PublicationDate_xml – month: 10
  year: 2017
  text: 2017-10-01
  day: 01
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
PublicationTitle The Lancet global health
PublicationTitleAlternate Lancet Glob Health
PublicationYear 2017
Publisher Elsevier Ltd
The Lancet Global Health
Elsevier
Publisher_xml – name: Elsevier Ltd
– name: The Lancet Global Health
– name: Elsevier
References Do, van Doorn, Nghiem (bib4) 2011; 6
Berger, Aebi, Duppenthaler, Stocker (bib25) 2009; 37
Giersing, Modjarrad, Kaslow, Moorthy (bib20) 2016; 34
(accessed May 3, 2016).
Shi, McAllister, O'Brien (bib5) 2017
Shay, Holman, Roosevelt, Clarke, Anderson (bib8) 2001; 183
Mccracken, Prill, Arvelo (bib19) 2013; 208
Leung, Lam, Miu (bib17) 2014; 42
Butt, Symington, Janes, Elliott, Steele, Paes (bib14) 2011; 170
Zhang, Guo, Langley, Bai (bib7) 2013; 6
Lee, Peng, Chiu, Huang, Huang, Chi (bib10) 2016; 49
Mauskopf, Margulis, Samuel, Lohr (bib27) 2016; 35
Mazur, Martinón-Torres, Baraldi (bib28) 2015; 3
Chi, Chang, Tsai (bib26) 2011; 110
Nair, Simões, Rudan (bib29) 2013; 381
WHO. Child growth standards.
Moyes, Cohen, Pretorius (bib18) 2013; 208
Modjarrad, Giersing, Kaslow, Smith, Moorthy (bib21) 2016; 34
Hall, Weinberg, Blumkin (bib15) 2013; 132
Fleming, Pannell, Cross (bib6) 2005; 59
The World Bank. Country and lending groups.
Welliver, Checchia, Bauman, Fernandes, Mahadevia, Hall (bib12) 2010; 26
Thorburn (bib11) 2009; 94
/
Geoghegan, Erviti, Caballero (bib16) 2017; 195
Byington, Wilkes, Korgenski, Sheng (bib24) 2014; 135
Nasreen, Luby, Brooks (bib3) 2014; 9
El Kholy, Mostafa, El-Sherbini (bib9) 2013; 55
Berkley, Munywoki, Ngama (bib2) 2010; 303
Lozano, Naghavi, Foreman (bib1) 2012; 380
Vizcarra-Ugalde, Rico-Hernández, Monjarás-Ávila (bib13) 2016; 35
Mccracken (10.1016/S2214-109X(17)30344-3_bib19) 2013; 208
Fleming (10.1016/S2214-109X(17)30344-3_bib6) 2005; 59
Giersing (10.1016/S2214-109X(17)30344-3_bib20) 2016; 34
Do (10.1016/S2214-109X(17)30344-3_bib4) 2011; 6
Welliver (10.1016/S2214-109X(17)30344-3_bib12) 2010; 26
Shi (10.1016/S2214-109X(17)30344-3_bib5) 2017
Mauskopf (10.1016/S2214-109X(17)30344-3_bib27) 2016; 35
Berkley (10.1016/S2214-109X(17)30344-3_bib2) 2010; 303
Butt (10.1016/S2214-109X(17)30344-3_bib14) 2011; 170
Geoghegan (10.1016/S2214-109X(17)30344-3_bib16) 2017; 195
Nasreen (10.1016/S2214-109X(17)30344-3_bib3) 2014; 9
Zhang (10.1016/S2214-109X(17)30344-3_bib7) 2013; 6
Shay (10.1016/S2214-109X(17)30344-3_bib8) 2001; 183
Moyes (10.1016/S2214-109X(17)30344-3_bib18) 2013; 208
10.1016/S2214-109X(17)30344-3_bib23
10.1016/S2214-109X(17)30344-3_bib22
Mazur (10.1016/S2214-109X(17)30344-3_bib28) 2015; 3
Hall (10.1016/S2214-109X(17)30344-3_bib15) 2013; 132
Leung (10.1016/S2214-109X(17)30344-3_bib17) 2014; 42
El Kholy (10.1016/S2214-109X(17)30344-3_bib9) 2013; 55
Modjarrad (10.1016/S2214-109X(17)30344-3_bib21) 2016; 34
Lee (10.1016/S2214-109X(17)30344-3_bib10) 2016; 49
Vizcarra-Ugalde (10.1016/S2214-109X(17)30344-3_bib13) 2016; 35
Berger (10.1016/S2214-109X(17)30344-3_bib25) 2009; 37
Thorburn (10.1016/S2214-109X(17)30344-3_bib11) 2009; 94
Byington (10.1016/S2214-109X(17)30344-3_bib24) 2014; 135
Nair (10.1016/S2214-109X(17)30344-3_bib29) 2013; 381
Lozano (10.1016/S2214-109X(17)30344-3_bib1) 2012; 380
Chi (10.1016/S2214-109X(17)30344-3_bib26) 2011; 110
28986050 - Lancet Glob Health. 2017 Dec;5(12 ):e1190
28911753 - Lancet Glob Health. 2017 Oct;5(10 ):e951-e952
References_xml – volume: 183
  start-page: 16
  year: 2001
  end-page: 22
  ident: bib8
  article-title: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997
  publication-title: J Infect Dis
– volume: 37
  start-page: 109
  year: 2009
  end-page: 116
  ident: bib25
  article-title: Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001–2005)
  publication-title: Infection
– volume: 34
  start-page: 2865
  year: 2016
  end-page: 2869
  ident: bib20
  article-title: Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015
  publication-title: Vaccine
– volume: 59
  start-page: 586
  year: 2005
  end-page: 590
  ident: bib6
  article-title: Mortality in children from influenza and respiratory syncytial virus
  publication-title: J Epidemiol Community Health
– reference: WHO. Child growth standards.
– volume: 35
  start-page: 1199
  year: 2016
  end-page: 1203
  ident: bib13
  article-title: Intensive care unit admission and death rates of infants admitted with respiratory syncytial virus lower respiratory tract infection in Mexico
  publication-title: Pediatr Infect Dis J
– volume: 195
  start-page: 96
  year: 2017
  end-page: 103
  ident: bib16
  article-title: Mortality due to respiratory syncytial virus: burden and risk factors
  publication-title: Am J Respir Crit Care Med
– volume: 55
  start-page: 283
  year: 2013
  end-page: 288
  ident: bib9
  article-title: Morbidity and outcome of severe respiratory syncytial virus infection
  publication-title: Pediatr Int
– volume: 49
  start-page: 737
  year: 2016
  end-page: 742
  ident: bib10
  article-title: Risk factors associated with death in patients with severe respiratory syncytial virus infection
  publication-title: J Microbiol Immunol Infect
– reference: The World Bank. Country and lending groups.
– volume: 35
  start-page: e229
  year: 2016
  end-page: e238
  ident: bib27
  article-title: Respiratory syncytial virus hospitalizations in healthy preterm infants: systematic review
  publication-title: Pediatr Infect Dis J
– volume: 9
  start-page: e89978
  year: 2014
  ident: bib3
  article-title: Population-based incidence of severe acute respiratory virus infections among children aged <5 years in rural Bangladesh, June–October 2010
  publication-title: PLoS One
– volume: 303
  start-page: 2051
  year: 2010
  end-page: 2057
  ident: bib2
  article-title: Viral etiology of severe pneumonia among Kenyan infants and children
  publication-title: JAMA
– volume: 6
  start-page: 447
  year: 2013
  ident: bib7
  article-title: Respiratory syncytial virus-associated intensive care unit admission in children in southern China
  publication-title: BMC Res Notes
– volume: 208
  start-page: S217
  year: 2013
  end-page: S226
  ident: bib18
  article-title: Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010–2011
  publication-title: J Infect Dis
– volume: 26
  start-page: 2175
  year: 2010
  end-page: 2181
  ident: bib12
  article-title: Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children
  publication-title: Curr Med Res Opin
– volume: 3
  start-page: 888
  year: 2015
  end-page: 900
  ident: bib28
  article-title: Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics
  publication-title: Lancet Respir Med
– reference: (accessed May 3, 2016).
– volume: 6
  start-page: e18176
  year: 2011
  ident: bib4
  article-title: Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004–2008
  publication-title: PLoS One
– volume: 42
  start-page: 343
  year: 2014
  end-page: 350
  ident: bib17
  article-title: Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children
  publication-title: Infection
– year: 2017
  ident: bib5
  article-title: Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
  publication-title: Lancet
– volume: 132
  start-page: e341
  year: 2013
  end-page: e348
  ident: bib15
  article-title: Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age
  publication-title: Pediatrics
– volume: 380
  start-page: 2095
  year: 2012
  end-page: 2128
  ident: bib1
  article-title: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
  publication-title: Lancet
– reference: /
– volume: 135
  start-page: e24
  year: 2014
  end-page: e31
  ident: bib24
  article-title: Respiratory syncytial virus-associated mortality in hospitalized infants and young children
  publication-title: Pediatrics
– volume: 110
  start-page: 388
  year: 2011
  end-page: 396
  ident: bib26
  article-title: Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007
  publication-title: J Formos Med Assoc
– volume: 94
  start-page: 99
  year: 2009
  end-page: 103
  ident: bib11
  article-title: Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection
  publication-title: Arch Dis Child
– volume: 208
  start-page: S197
  year: 2013
  end-page: S206
  ident: bib19
  article-title: Respiratory syncytial virus infection in Guatemala, 2007–2012
  publication-title: J Infect Dis
– volume: 170
  start-page: 907
  year: 2011
  end-page: 913
  ident: bib14
  article-title: The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study
  publication-title: Eur J Pediatr
– volume: 381
  start-page: 1380
  year: 2013
  end-page: 1390
  ident: bib29
  article-title: Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis
  publication-title: Lancet
– volume: 34
  start-page: 190
  year: 2016
  end-page: 197
  ident: bib21
  article-title: WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015
  publication-title: Vaccine
– volume: 208
  start-page: S217
  year: 2013
  ident: 10.1016/S2214-109X(17)30344-3_bib18
  article-title: Epidemiology of respiratory syncytial virus-associated acute lower respiratory tract infection hospitalizations among HIV-infected and HIV-uninfected South African children, 2010–2011
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jit479
– ident: 10.1016/S2214-109X(17)30344-3_bib22
– volume: 34
  start-page: 190
  year: 2016
  ident: 10.1016/S2214-109X(17)30344-3_bib21
  article-title: WHO consultation on Respiratory Syncytial Virus Vaccine Development Report from a World Health Organization Meeting held on 23–24 March 2015
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2015.05.093
– volume: 170
  start-page: 907
  year: 2011
  ident: 10.1016/S2214-109X(17)30344-3_bib14
  article-title: The impact of prophylaxis on paediatric intensive care unit admissions for RSV infection: a retrospective, single-centre study
  publication-title: Eur J Pediatr
  doi: 10.1007/s00431-010-1376-3
– volume: 135
  start-page: e24
  year: 2014
  ident: 10.1016/S2214-109X(17)30344-3_bib24
  article-title: Respiratory syncytial virus-associated mortality in hospitalized infants and young children
  publication-title: Pediatrics
  doi: 10.1542/peds.2014-2151
– volume: 380
  start-page: 2095
  year: 2012
  ident: 10.1016/S2214-109X(17)30344-3_bib1
  article-title: Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)61728-0
– volume: 26
  start-page: 2175
  year: 2010
  ident: 10.1016/S2214-109X(17)30344-3_bib12
  article-title: Fatality rates in published reports of RSV hospitalizations among high-risk and otherwise healthy children
  publication-title: Curr Med Res Opin
  doi: 10.1185/03007995.2010.505126
– volume: 303
  start-page: 2051
  year: 2010
  ident: 10.1016/S2214-109X(17)30344-3_bib2
  article-title: Viral etiology of severe pneumonia among Kenyan infants and children
  publication-title: JAMA
  doi: 10.1001/jama.2010.675
– volume: 6
  start-page: 447
  year: 2013
  ident: 10.1016/S2214-109X(17)30344-3_bib7
  article-title: Respiratory syncytial virus-associated intensive care unit admission in children in southern China
  publication-title: BMC Res Notes
  doi: 10.1186/1756-0500-6-447
– volume: 37
  start-page: 109
  year: 2009
  ident: 10.1016/S2214-109X(17)30344-3_bib25
  article-title: Prospective population-based study of RSV-related intermediate care and intensive care unit admissions in Switzerland over a 4-year period (2001–2005)
  publication-title: Infection
  doi: 10.1007/s15010-008-8130-z
– volume: 195
  start-page: 96
  year: 2017
  ident: 10.1016/S2214-109X(17)30344-3_bib16
  article-title: Mortality due to respiratory syncytial virus: burden and risk factors
  publication-title: Am J Respir Crit Care Med
  doi: 10.1164/rccm.201603-0658OC
– volume: 381
  start-page: 1380
  year: 2013
  ident: 10.1016/S2214-109X(17)30344-3_bib29
  article-title: Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis
  publication-title: Lancet
  doi: 10.1016/S0140-6736(12)61901-1
– volume: 9
  start-page: e89978
  year: 2014
  ident: 10.1016/S2214-109X(17)30344-3_bib3
  article-title: Population-based incidence of severe acute respiratory virus infections among children aged <5 years in rural Bangladesh, June–October 2010
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0089978
– volume: 208
  start-page: S197
  year: 2013
  ident: 10.1016/S2214-109X(17)30344-3_bib19
  article-title: Respiratory syncytial virus infection in Guatemala, 2007–2012
  publication-title: J Infect Dis
  doi: 10.1093/infdis/jit517
– volume: 59
  start-page: 586
  year: 2005
  ident: 10.1016/S2214-109X(17)30344-3_bib6
  article-title: Mortality in children from influenza and respiratory syncytial virus
  publication-title: J Epidemiol Community Health
  doi: 10.1136/jech.2004.026450
– volume: 94
  start-page: 99
  year: 2009
  ident: 10.1016/S2214-109X(17)30344-3_bib11
  article-title: Pre-existing disease is associated with a significantly higher risk of death in severe respiratory syncytial virus infection
  publication-title: Arch Dis Child
  doi: 10.1136/adc.2008.139188
– volume: 132
  start-page: e341
  year: 2013
  ident: 10.1016/S2214-109X(17)30344-3_bib15
  article-title: Respiratory syncytial virus-associated hospitalizations among children less than 24 months of age
  publication-title: Pediatrics
  doi: 10.1542/peds.2013-0303
– volume: 35
  start-page: e229
  year: 2016
  ident: 10.1016/S2214-109X(17)30344-3_bib27
  article-title: Respiratory syncytial virus hospitalizations in healthy preterm infants: systematic review
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000001163
– ident: 10.1016/S2214-109X(17)30344-3_bib23
– volume: 6
  start-page: e18176
  year: 2011
  ident: 10.1016/S2214-109X(17)30344-3_bib4
  article-title: Viral etiologies of acute respiratory infections among hospitalized Vietnamese children in Ho Chi Minh City, 2004–2008
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0018176
– volume: 183
  start-page: 16
  year: 2001
  ident: 10.1016/S2214-109X(17)30344-3_bib8
  article-title: Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979–1997
  publication-title: J Infect Dis
  doi: 10.1086/317655
– volume: 49
  start-page: 737
  year: 2016
  ident: 10.1016/S2214-109X(17)30344-3_bib10
  article-title: Risk factors associated with death in patients with severe respiratory syncytial virus infection
  publication-title: J Microbiol Immunol Infect
  doi: 10.1016/j.jmii.2014.08.020
– volume: 34
  start-page: 2865
  year: 2016
  ident: 10.1016/S2214-109X(17)30344-3_bib20
  article-title: Report from the World Health Organization's Product Development for Vaccines Advisory Committee (PDVAC) meeting, Geneva, 7–9th Sep 2015
  publication-title: Vaccine
  doi: 10.1016/j.vaccine.2016.02.078
– volume: 55
  start-page: 283
  year: 2013
  ident: 10.1016/S2214-109X(17)30344-3_bib9
  article-title: Morbidity and outcome of severe respiratory syncytial virus infection
  publication-title: Pediatr Int
  doi: 10.1111/ped.12051
– volume: 42
  start-page: 343
  year: 2014
  ident: 10.1016/S2214-109X(17)30344-3_bib17
  article-title: Epidemiology and risk factors for severe respiratory syncytial virus infections requiring pediatric intensive care admission in Hong Kong children
  publication-title: Infection
  doi: 10.1007/s15010-013-0557-1
– volume: 35
  start-page: 1199
  year: 2016
  ident: 10.1016/S2214-109X(17)30344-3_bib13
  article-title: Intensive care unit admission and death rates of infants admitted with respiratory syncytial virus lower respiratory tract infection in Mexico
  publication-title: Pediatr Infect Dis J
  doi: 10.1097/INF.0000000000001262
– volume: 110
  start-page: 388
  year: 2011
  ident: 10.1016/S2214-109X(17)30344-3_bib26
  article-title: Epidemiological study of hospitalization associated with respiratory syncytial virus infection in Taiwanese children between 2004 and 2007
  publication-title: J Formos Med Assoc
  doi: 10.1016/S0929-6646(11)60057-0
– volume: 3
  start-page: 888
  year: 2015
  ident: 10.1016/S2214-109X(17)30344-3_bib28
  article-title: Lower respiratory tract infection caused by respiratory syncytial virus: current management and new therapeutics
  publication-title: Lancet Respir Med
  doi: 10.1016/S2213-2600(15)00255-6
– year: 2017
  ident: 10.1016/S2214-109X(17)30344-3_bib5
  article-title: Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study
  publication-title: Lancet
  doi: 10.1016/S0140-6736(17)30938-8
– reference: 28986050 - Lancet Glob Health. 2017 Dec;5(12 ):e1190
– reference: 28911753 - Lancet Glob Health. 2017 Oct;5(10 ):e951-e952
SSID ssj0000993277
Score 2.52998
Snippet Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV infection are...
Background Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV...
Background: Respiratory syncytial virus (RSV) infection is an important cause of pneumonia mortality in young children. However, clinical data for fatal RSV...
SourceID doaj
pubmedcentral
csuc
proquest
pubmed
crossref
elsevier
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage e984
SubjectTerms Child, Preschool
Children
Female
Global Health - statistics & numerical data
Humans
Infant
Infant, Newborn
Infants
Malalties de l'aparell respiratori
Male
Respiratory organs diseases
Respiratory Syncytial Virus Infections - mortality
Retrospective Studies
SummonAdditionalLinks – databaseName: Directory of Open Access Journals (DOAJ)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQnpAQ4k14yUgcWqTQxM-YG69SIR4SpWhvlu046qKShSSL1H_POE7SDRyWA4ccYmes2DOZ-Rx7PiP0xFQys4rkKYQqmrKSqlRVzqWCZNwoxqzs_3d8-CiOTti7JV9uHfUV9oRFeuA4cAcirypaAY4WyjFXKOsFJZYRKyXnnvapexDztiZT3yLuoaQ_dpGQnIGvUcuL9J2D46lwL5f7NLDepXQWmBau3biBxn8Wpv6GoX_uptwKT4fX0NUBV-IXsT_X0SVf30BX4k85HHONbqKfkeEfNxfr67g9B_cKn_kZ_rVqNm1qBn35En_voTnAdLyq8XlwC3jM_cZ7n4-_4ref3r_ef44NNNg16zFpEzuIjDiYtm9voZPDN19eHaXDmQupE0R1KS8hvvOKcMuYLyteAuICkECVCUukRnlbZIGSDVCML7KKWA_PglugUG5Kl9HbaFGva38XYQ-VzAgQqUxgabMcJne8LEpnDSjQJ4iNA67dQEgezsU409POs6CnsEa-1LnUvZ40TdCzSexHZOTYJfA0aFNDBPGNM50OjNrTTbhIJokG3COkStDLoPOp5fBsXwA2qQeb1LtsMkFitBg9JriCS4aGVrtetZgEBwQUkc2_iD4eTVODhwjLPqb2602rcxX8tKIqS9CdaKpT90AjeS4FS5CcGfGs__OaenXas5AHqjqasXv_Y8Duo8skwKV-k-QDtOiajX8IYK-zj_rv-jcd3Eos
  priority: 102
  providerName: Directory of Open Access Journals
Title Global respiratory syncytial virus-associated mortality in young children (RSV GOLD): a retrospective case series
URI https://www.clinicalkey.com/#!/content/1-s2.0-S2214109X17303443
https://dx.doi.org/10.1016/S2214-109X(17)30344-3
https://www.ncbi.nlm.nih.gov/pubmed/28911764
https://www.proquest.com/docview/1940049390
https://recercat.cat/handle/2072/293679
https://pubmed.ncbi.nlm.nih.gov/PMC5599304
https://doaj.org/article/61ff3f55069c4c89be632b42b7755e39
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Jb9UwELaqd0JCiLI-lspIHFqk8BLbWcyNFkqFWCRKUW6W7TglUslrkzyk_ntmnKUEDkUccojjGcWZ8cwXe2ZMyHNdpqGRLArAVfFAFFwGsrQ2SFgYaymESf16x8dPydGJeJ_H-RY5GHNhMKxysP29TffWemhZDV9zdV5Vq2PGMEZR5hEoKRcCK35ykfkkvnx_WmcBBMSZP4AR-wdIcJXI0zPxjbtRuuf5BHzmoha23dihoP_MYf0NSP-Mq_zNUR3eJrcGhElf94PYJluuvkNu9stztM86uksu-lr_tLnaaaftJRhamPBn9GfVbNpAD5JzBf3hQToAdlrV9BINBB2zwOnul-Nv9N3nD2_2XlENDLtmPaZvUgs-kqKSu_YeOTl8-_XgKBhOXwhswmQXxAV4-rhksRHCFWVcAPYCuMClxs1SLZ3JQizOBnjGZWHJjIO-YCA4tOvChvw-WdTr2j0k1MFDoRMgKTXWazMx_ObFRVZYo41gbknE-MGVHUqT4wkZZ2qKQUM54W55rqJUeTkpviQvJ7LzvjbHdQQvUJoK9Mo1VncKa2tPN3ixMGUKEFCSyiXZR5lPnLGvb1g3p2pQRJVEZclL-MtLpBU2k8YlnMGQTJrGsePAJBk1Ro2prmCcgVF13atmE-FsPvwL6bNRNRXYCtwA0rVbb1oVSbTYkstwSR70qjoNDyQSRWkiliSdKfFs_PMndfXd1yPHonU8FI_-_5UfkxsM4ZIPknxCFl2zcU8B7HVmxy-S7Pg5_QumqUv1
linkProvider Elsevier
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwELbKcgAJId4sTyNxaJHCJrYTr7nRQtnCtkj0odwsx3EgUsmW7C5S_z0zzqMEDkUccoiTGcWZ8cxne2ZMyEtTyDBTLArAVfFA5FwFqrA2SFgYGyVEJv16x_5BMjsWH9M43SA7XS4MhlW2tr-x6d5aty2T9m9OzspycsgYxiiqNAIl5ULwK-QqoAGJo3Mv3e4XWgACceZPYESCACkuMnkaLr5xM5JbnlHABz5qZJdr21b0H3isvxHpn4GVv3mq3VvkZgsx6dumF7fJhqvukBvN-hxt0o7ukh9NsX9aX2y10-U5WFoY8af0Z1mvl4FpRedy-t2jdEDstKzoOVoI2qWB080vhyf0w-f5u6031ADDVb3o8jepBSdJUcvd8h453n1_tDML2uMXApswtQriHFx9XLA4E8LlRZwD-AK8wJXB3VKjXDYNsTobABo3DQuWOXgXLASHdpPbkN8no2pRuYeEOngoTAIkhcGCbVkM87w4n-Y2M5lgbkxE98O1bWuT4xEZp7oPQkM54XZ5qiOpvZw0H5PXPdlZU5zjMoJXKE0NiuVqa1Yai2v3N3ixUDINECiRaky2UeY9Z3zXNyzqr7rVRJ1ERcELmOYlygo7VZlLOIMuZVLGsePAJOk0Rne5rmCdgVF52adOe8LBgPgX0hedamowFrgDZCq3WC91pNBkK67CMXnQqGrfPZBIFMlEjIkcKPGg_8MnVfnNFyTHqnU8FI_-_5Ofk2uzo_25nu8dfHpMrjPETj5i8gkZreq1ewrIb5U98yP7F3yATiA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Global+respiratory+syncytial+virus-associated+mortality+in+young+children+%28RSV+GOLD%29%3A+a+retrospective+case+series&rft.jtitle=The+Lancet+global+health&rft.au=Scheltema%2C+Nienke+M&rft.au=Gentile%2C+Angela&rft.au=Lucion%2C+Florencia&rft.au=Nokes%2C+D+James&rft.date=2017-10-01&rft.issn=2214-109X&rft.eissn=2214-109X&rft.volume=5&rft.issue=10&rft.spage=e984&rft_id=info:doi/10.1016%2FS2214-109X%2817%2930344-3&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2214-109X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2214-109X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2214-109X&client=summon